Health care costs were rising. People couldn’t afford coverage. So, in Connecticut, state lawmakers took action.
President Donald Trump offered a preview of what his 2020 health agenda might look like in a speech last week — blasting Democratic proposals for reform and saying he would tackle issues such as prescription drug prices and affordability.
Cancer is not one disease, but many; and finding cures is only part of the problem
City and county public health officials are urging the Trump administration to go bigger in its response to adolescents’ growing use of e-cigarettes.
Democrats with 2020 presidential aspirations are courting the party’s increasingly influential progressive wing and staking out ambitious policy platforms. Front and center are three words: Medicare. For. All. That simple phrase is loaded with political baggage, and often accompanied by vague promises and complex jargon. Different candidates use it to target different voter blocs, leading to sometimes divergent, even contradictory ideas.
Presidential candidates are already trying to stake a claim to one of health care’s hot-button concerns: surging prescription drug prices.
This week, Vermont passed a first-in-the-nation law that would facilitate the state’s importation of prescription drugs wholesale from Canada. It represents the state’s effort to tackle head-on the issue of constantly climbing drug prices.
In the absence of new federal policies to tame break-the-bank drug prices, Massachusetts’ state Medicaid program hopes to road-test an idea both radical and market-driven. It wants the power to negotiate discounts for the drugs it purchases and to exclude drugs with limited treatment value. Connecticut is watching.
As Dr. Ruth Berggren digests the calamity affecting her new home state of Texas, she admits to some PTSD. She knows firsthand the trauma suffered by the medical personnel trying to keep people healthy under devastating circumstances.
A provision of the 2010 federal health law linking hospital payments to patient satisfaction surveys may be complicating national efforts to curb the use of opioids and address the epidemic of painkiller abuse.
Every day, headlines detail the casualties of the nation’s surge in heroin and prescription painkiller abuse: the funerals, the broken families and the patients cycling in and out of treatment. Now, a new study sheds light on another repercussion — how this public health problem is adding to the nation’s ballooning health care costs and who’s shouldering that burden.
The military’s health program falls significantly short in providing mental health care to active service members, according to a RAND Corp. study published Thursday. The study focuses on post-traumatic stress disorder and depression, the two most common mental health conditions experienced in the armed services.
Sparking strong reaction from doctors and child development experts, an influential task force says there’s “insufficient evidence” to argue definitely that the benefits of screening all young children for autism outweigh the harms.
As hospitals chase better patient ratings and health outcomes, an increasing number are rethinking how they function at night so more patients can sleep relatively uninterrupted.